Literature DB >> 15201460

Neurotransmitter receptor analysis in transgenic mouse models.

Caroline L Benn1, Laurie A Farrell, Jang-Ho J Cha.   

Abstract

One of the characteristic findings in human Huntington's disease (HD) is the alteration of neurotransmitter receptors. To a remarkable degree, transgenic HD mouse models recapitulate neurotransmitter receptor alterations. Neurotransmitter receptors can be assessed at the protein level by using receptor-binding autoradiography. One can also measure levels of receptor messenger RNA with in situ hybridization (ISH), employing either oligonucleotide or ribonucleotide probes. Both of these techniques-receptor-binding autoradiography and in situ hybridization-yield quantitative and regionally specific information regarding neurotransmitter receptors. We describe techniques for performing receptor-binding autoradiography and two types of in situ hybridization using oligonucleotide and ribonucleotide probes. With receptor binding and ISH, one can obtain quantitative region-specific assessments of neurotransmitter receptor alteration, a key pathologic event in HD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201460     DOI: 10.1385/1-59259-804-8:231

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.

Authors:  Fumiaki Yokoi; Mai T Dang; Jun Liu; Jason R Gandre; Kelly Kwon; Robert Yuen; Yuqing Li
Journal:  Behav Brain Res       Date:  2014-11-29       Impact factor: 3.332

2.  Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease.

Authors:  Danqing Xiao; Jared J Cassin; Brian Healy; Thomas C Burdett; Jiang-Fan Chen; Bertil B Fredholm; Michael A Schwarzschild
Journal:  Brain Res       Date:  2010-09-07       Impact factor: 3.252

3.  An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Chad C Cheetham; Jun Lu; Viet Vo; David M Lovinger; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-08       Impact factor: 3.332

4.  HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.

Authors:  Victoria S Dalton; Hongqin Wang; Katerina Zavitsanou
Journal:  Neurochem Res       Date:  2009-01-24       Impact factor: 3.996

5.  Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease.

Authors:  C L Benn; E J Slow; L A Farrell; R Graham; Y Deng; M R Hayden; J-H J Cha
Journal:  Neuroscience       Date:  2007-06-04       Impact factor: 3.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.